CDT Partners with Manoira to Explore Enhancing Animal Health Products Ahead of Launch
CDT Equity entered an evaluation agreement with Manoira Corporation to assess whether CDT's clinical-stage assets AZD1656 and AZD5904 can enhance Manoira's upcoming animal health products. Manoira plans to launch its first animal health range in Q1 2027 using licensed cannabinoid cocrystal and solid-form technologies, and is currently in manufacturing and testing.
Key figures
- Drug Name
- AZD1656 and AZD5904
- Partner launch target
- Q1 2027
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.